Page last updated: 2024-10-19

niacinamide and Pheochromocytoma

niacinamide has been researched along with Pheochromocytoma in 4 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)

Research Excerpts

ExcerptRelevanceReference
"Pheochromocytoma cells (clone PC-12) were treated with 6-aminonicotinamide."7.67Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide. ( Herken, H; Jung, W, 1989)
"Pheochromocytoma cells (clone PC-12) were treated with 6-aminonicotinamide."3.67Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide. ( Herken, H; Jung, W, 1989)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denorme, M1
Yon, L1
Roux, C1
Gonzalez, BJ1
Baudin, E1
Anouar, Y1
Dubessy, C1
Maksimovic, O1
Schraml, C1
Hartmann, JT1
Bitzer, M1
Claussen, CD1
Pintoffl, J1
Horger, M1
Jung, W1
Herken, H1
Davis, LH1
Kauffman, FC1

Other Studies

4 other studies available for niacinamide and Pheochromocytoma

ArticleYear
Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
    Cancer letters, 2014, Oct-01, Volume: 352, Issue:2

    Topics: Administration, Oral; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Sur

2014
Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment.
    AJR. American journal of roentgenology, 2010, Volume: 194, Issue:1

    Topics: Adrenal Gland Neoplasms; Aged; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell;

2010
Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.
    Naunyn-Schmiedeberg's archives of pharmacology, 1989, Volume: 339, Issue:4

    Topics: 6-Aminonicotinamide; Alcohol Oxidoreductases; Animals; Biopterins; Chromatography, High Pressure Liq

1989
Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide.
    Neurochemical research, 1987, Volume: 12, Issue:6

    Topics: 6-Aminonicotinamide; Adrenal Gland Neoplasms; Animals; Carbon Dioxide; Cell Line; Gluconates; Glucos

1987